Page 29 - Vaccine

Top headlines: Grasim Q4 net rises 13%; BSE sees a new milestone

Business Standard brings you the top news of the evening

Covid-19 crisis: Punjab says Moderna refused to send vaccines directly

The world's largest vaccine-producing nation has fully vaccinated a little more than 41.6 million people, or only 3.8 per cent of its 1.35 billion population

G20 leaders vow unity; to boost vaccine access to fight Covid-19 pandemic

To sign 'Declaration of Rome'- guiding principles that prioritise multilateralism

Inheritance of ideas

In the midst of a raging debate over IP rights, the million-dollar question is who owns the vaccine? Is it the pharma firms, the country origin, the university they are developed in or the people?

The confidence that proved disastrous

The government has been inept in all that was required of it

I didn't 'destroy' India's self-sufficiency in vaccine production: Ramadoss

The Union health minister in the first term of the UPA government, Anbumani Ramadoss clarifies he did not close down govt-run vaccine manufacturing units

Daily Covid-19 cases below 300k after a 26-day run: Health ministry

Cases still rising in many parts; 20% plus positivity in 244 districts

Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic

The ongoing April-June quarter should see strong growth due to low base of last year

The way forward for firms

Indian firms need to prepare for export boom by vaccinating employees, their family members; and prioritise export market

Best of BS Opinion: Herbs need good marketing, second Covid-19 wave & more

Here are the best of Business Standard's opinion pieces for Monday

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech

Vaccine effective against all emerging coronavirus variants, says study

Cipla open to forge a partnership to distribute Covid-19 vaccines in India

The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)

India would be reasonable in extending gap between Covishield shots: Fauci

'When you're in a difficult situation, as you are in India, you have to figure out ways to get as many people vaccinated as you quickly as you can do," Fauci said

Bharat Biotech unit to make Pune plant functional for vax production by Aug

Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune fully functional for vaccine production by August-end, a senior administrative official said

Centre will provide assistance to companies willing to manufacture vaccines

The central government on Thursday said it will provide all possible assistance to all companies willing to manufacture the vaccine to ramp up the supply

Govt increases gap between two doses of Covishield to 12-16 weeks

States told to ensure adherence to revised schedule

Blue Dart to operate drones for delivery of vaccines and medicines

The Ministry of Civil Aviation (MoCA) has granted the project with necessary exemptions and rights to fly drone flights on an experimental basis in Telangana

Make GST zero for Covid-19 vaccines, drugs: Tamil Nadu CM tells PM Modi

Tamil Nadu Chief Minister M K Stalin on Thursday urged Prime Minister Narendra Modi to bring the Goods and Services Tax for COVID-19 vaccines and drugs to zero level. Pending GST compensation and subsidy on rice should be released immediately and adhoc grants-in-aid must be provided as the Centre has not shared with states the revenue from additional levies on fuel, he said in a letter to Modi. Also, Stalin wanted the borrowing limit increased by one more per cent from the current three per cent of Gross State Domestic Product. State governments were procuring COVID-19 vaccines and drugs to treat the patients and the GST for such supplies should be made zero, he said. At a time when the tax revenue of states have seen a steep decline on account of economic growth taking a hit in view of the pandemic, measures including release of GST compensation should be taken up by the Centre to help the state governments.

Damaged reputation

India's Covid crisis has implications for supply chain and soft power

Vaccination 'clear way' of protecting people from Covid-19: Tata group exec

Faster vaccination with more vaccines from wider manufacturers approved with due process, way of making sure that people are safe from Covid-19, according a senior official of the Tata group.